MiSight 1 day is a single-use, daily-wear soft contact lens that corrects myopia while its dual-focus optical design is intended to slow myopia progression in eligible children. In the United States, the FDA indication applies to children with non-diseased eyes who begin treatment at ages 8 to 12 and meet the labeled refractive criteria. An eye examination and contact lens fitting are required to determine candidacy.
MiSight 1 Day Parameters
The current U.S. manufacturer information lists the following product specifications. Availability and labeling can change, so the prescription and package insert provided by the fitting professional should control.
| Parameter | MiSight 1 Day |
|---|---|
| Material | omafilcon A |
| Replacement schedule | Single use; discard after each removal |
| Wear schedule | Daily wear; not approved for overnight wear |
| Base curve | 8.7 mm |
| Diameter | 14.2 mm |
| U.S. sphere power availability | -0.50 D to -7.00 D, with 0.50 D steps after -6.00 D; no plano |
| Optical design | Dual-focus design with correction and treatment zones |
A product’s available power range is not the same as its FDA treatment indication. The current U.S. label, examination findings, fit, vision, ocular health, age at initiation, refractive error, astigmatism, and ability to wear contact lenses all affect whether MiSight is appropriate.
What Is the FDA Indication for MiSight 1 Day?
The FDA originally approved MiSight 1 day for correction of myopic ametropia and for slowing myopia progression in children with non-diseased eyes who are 8 to 12 years old when treatment begins. The approved refractive range at initiation is -0.75 to -4.00 diopters spherical equivalent with no more than 0.75 diopters of astigmatism. The lens is discarded after each removal.
That wording matters. FDA approval does not mean every child in the age or prescription range is a candidate, and it does not guarantee a particular amount of treatment effect. The fitting professional must evaluate ocular health, binocular vision, refractive findings, contact lens readiness, hygiene, and the child’s and family’s ability to follow the wear plan.
How Does MiSight 1 Day Work?
MiSight uses concentric optical zones. Two correction zones provide the distance prescription, while two treatment zones create myopic defocus in front of the retina. The design is intended to provide clear vision while reducing the visual signal associated with excessive axial elongation.
Myopia progression is commonly tracked with cycloplegic refraction and, when available and clinically appropriate, axial length. A child may see clearly through a lens even while myopia is still changing, so scheduled measurements remain important.
What Did the Clinical Trial Find?
In the three-year randomized, double-masked clinical trial that supported the product, children wearing MiSight had less average change in spherical equivalent refraction and axial length than children wearing a single-vision daily disposable control lens. The published study reported 59% less refractive progression and 52% less axial elongation in the MiSight group over three years.
These percentages compare group averages in a controlled study. They should not be interpreted as a promise that an individual child’s myopia will slow by the same amount. Response varies, and ongoing monitoring is needed to determine whether the treatment plan remains appropriate.
Who May Be a Candidate?
A MiSight evaluation may be reasonable for a child who meets the current labeled criteria, has progressing myopia or a clinical reason to discuss myopia management, has healthy eyes, can achieve acceptable vision and fit with the lens, and can safely manage daily contact lens wear with parent or caregiver support.
Candidacy may be affected by significant astigmatism, an unavailable prescription, active eye disease, ocular surface problems, poor hygiene, inability to insert or remove lenses, unreliable follow-up, or other contact lens contraindications. A child who does not fit the label or product parameters may need a different evidence-based option.
What Happens During a MiSight Fitting?
- Baseline examination: The clinician reviews medical and ocular history, refraction, binocular vision, corneal health, and myopia progression.
- Lens selection and on-eye assessment: The prescribed power is placed on the eye and evaluated for centration, movement, coverage, comfort, and vision.
- Insertion and removal training: The child and caregiver must demonstrate safe handling before lenses are dispensed.
- Follow-up: The clinician checks vision, fit, ocular health, wear habits, and treatment response at scheduled visits.
- Ongoing monitoring: Refraction and, when used, axial length are compared over time rather than judging treatment by day-to-day clarity alone.
Daily Wear and Safety
MiSight is a daily disposable lens. A fresh lens is applied for each day of wear and discarded after removal. It should not be slept in, reused, shared, exposed to tap water, or worn while swimming unless the prescribing professional has given specific protective instructions consistent with safe contact lens practice.
Hands should be washed with soap and dried with a clean, lint-free towel before touching a lens or eye. Pain, redness, light sensitivity, discharge, sudden blur, or persistent discomfort requires prompt lens removal and contact with the eye-care professional. Contact lens wear can cause serious complications, including infection, even when a lens is FDA approved.
Benefits and Limitations
Potential benefits include distance-vision correction, a daily disposable schedule, and evidence from controlled trials that the design can slow average myopia progression in the studied population. Daily disposal removes the need to clean and store a used lens, although safe handling is still essential.
Limitations include the fixed base curve and diameter, a spherical power range, labeled age and refractive criteria, the need for contact lens skills and follow-up, variable individual response, cost, and the possibility that vision, comfort, fit, or ocular health will not be acceptable. MiSight does not cure myopia, permanently stop eye growth, or eliminate future eye-health risks.
How Does MiSight Compare With Other Myopia Management Options?
Other approaches may include specialty spectacle lenses, orthokeratology, other multifocal or dual-focus contact lens designs, low-dose atropine prescribed by an appropriate clinician, and behavioral guidance such as regular outdoor time. Availability, evidence, regulatory status, benefits, risks, and suitability differ by option. The childhood myopia management guide explains how Eye Freedom evaluates these decisions.
No method is best for every child. The choice depends on age, rate of progression, refraction, astigmatism, binocular vision, ocular health, lifestyle, treatment goals, ability to follow the plan, and family preferences. Combining treatments should be based on a clinician’s assessment rather than on the assumption that more treatment is always better.
Dr. Boshnick’s Approach to Myopia Management
Dr. Edward Boshnick evaluates the child rather than recommending a product from a prescription alone. The examination considers visual needs, progression, eye health, contact lens readiness, product parameters, family support, and realistic expectations. If MiSight is not a good match, other correction or myopia-management options may be discussed or coordinated with the appropriate professional.
Eye Freedom does not present trial averages as guaranteed patient results. The purpose of follow-up is to confirm that the lens remains healthy to wear, provides useful vision, and is part of a plan that responds to the child’s actual measurements over time.
Frequently Asked Questions
What are the MiSight 1 Day base curve and diameter?
The current U.S. manufacturer specifications list an 8.7 mm base curve and 14.2 mm diameter. These fixed parameters still require an on-eye assessment because a prescription alone cannot confirm fit.
What powers are available in MiSight 1 Day?
The current U.S. professional product page lists sphere powers from -0.50 D to -7.00 D, with 0.50 D steps after -6.00 D and no plano. Product availability can change and does not expand the FDA-labeled treatment criteria.
At what age can a child start MiSight?
The U.S. FDA indication applies to children who are 8 to 12 years old when treatment begins and who meet the other labeled criteria. A clinician must confirm candidacy and current labeling.
Can MiSight permanently stop myopia?
No. MiSight is intended to slow progression, not cure myopia or guarantee that progression will stop. The prescription and eye length may still change, which is why follow-up measurements are important.
Can a child sleep in MiSight lenses?
No. MiSight is indicated for daily wear and single use. The lens should be removed before sleep and discarded after removal.
Does MiSight work for astigmatism?
MiSight is a spherical lens rather than a toric design. The FDA indication includes no more than 0.75 D of astigmatism at treatment initiation. Vision and fit must be evaluated on the eye.
Request a Myopia Management Evaluation
Read what parents can expect during a MiSight 1 Day fitting for a child. To learn whether MiSight or another approach may fit your child’s needs, request an evaluation with Eye Freedom. Bring prior prescriptions or eye-growth measurements when available so progression can be reviewed.
Medical and Product Sources
- U.S. Food and Drug Administration: MiSight 1 Day premarket approval and indication
- CooperVision U.S. professional product details and current parameters
- Randomized clinical trial: Three-year MiSight myopia-control outcomes
- Peer-reviewed study: Six-year cumulative MiSight treatment effect
- Peer-reviewed study: Eye growth after cessation of MiSight treatment
This article is educational and does not replace an eye examination, contact lens prescription, or individualized myopia-management plan. Product labeling and availability should be confirmed at the time of care.
